Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

New psychoactive substances of natural origin: A brief review.

Feng LY, Battulga A, Han E, Chung H, Li JH.

J Food Drug Anal. 2017 Jul;25(3):461-471. doi: 10.1016/j.jfda.2017.04.001. Epub 2017 Apr 18. Review.

2.

The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse.

Kruegel AC, Grundmann O.

Neuropharmacology. 2018 May 15;134(Pt A):108-120. doi: 10.1016/j.neuropharm.2017.08.026. Epub 2017 Aug 19. Review.

PMID:
28830758
3.

Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia.

Singh D, Narayanan S, Vicknasingam B, Corazza O, Santacroce R, Roman-Urrestarazu A.

Hum Psychopharmacol. 2017 May;32(3). doi: 10.1002/hup.2582. Epub 2017 May 24. Review.

PMID:
28544011
4.

A botanical, phytochemical and ethnomedicinal review of the genus Mitragyna korth: Implications for products sold as kratom.

Brown PN, Lund JA, Murch SJ.

J Ethnopharmacol. 2017 Apr 18;202:302-325. doi: 10.1016/j.jep.2017.03.020. Epub 2017 Mar 19. Review.

PMID:
28330725
5.

Herbal Highs: Review on Psychoactive Effects and Neuropharmacology.

Graziano S, Orsolini L, Rotolo MC, Tittarelli R, Schifano F, Pichini S.

Curr Neuropharmacol. 2017;15(5):750-761. doi: 10.2174/1570159X14666161031144427. Review.

6.

Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature.

Singh D, Narayanan S, Vicknasingam B.

Brain Res Bull. 2016 Sep;126(Pt 1):41-46. doi: 10.1016/j.brainresbull.2016.05.004. Epub 2016 May 10. Review.

PMID:
27178014
7.

Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busardò FP, Marinelli E.

Int J Mol Sci. 2016 Apr 16;17(4):580. doi: 10.3390/ijms17040580. Review.

8.

A Case Report of Kratom Addiction and Withdrawal.

Galbis-Reig D.

WMJ. 2016 Feb;115(1):49-52; quiz 53. Review.

9.

Neurobiology of Kratom and its main alkaloid mitragynine.

Suhaimi FW, Yusoff NH, Hassan R, Mansor SM, Navaratnam V, Müller CP, Hassan Z.

Brain Res Bull. 2016 Sep;126(Pt 1):29-40. doi: 10.1016/j.brainresbull.2016.03.015. Epub 2016 Mar 25. Review.

PMID:
27018165
10.

Herbal Supplements and Hepatotoxicity: A Short Review.

Haslan H, Suhaimi FH, Das S.

Nat Prod Commun. 2015 Oct;10(10):1779-84. Review.

PMID:
26669124
11.

Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Cinosi E, Martinotti G, Simonato P, Singh D, Demetrovics Z, Roman-Urrestarazu A, Bersani FS, Vicknasingam B, Piazzon G, Li JH, Yu WJ, Kapitány-Fövény M, Farkas J, Di Giannantonio M, Corazza O.

Biomed Res Int. 2015;2015:968786. doi: 10.1155/2015/968786. Epub 2015 Nov 10. Review.

12.

The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.

Warner ML, Kaufman NC, Grundmann O.

Int J Legal Med. 2016 Jan;130(1):127-38. doi: 10.1007/s00414-015-1279-y. Epub 2015 Oct 28. Review.

PMID:
26511390
13.

New drugs of abuse.

Rech MA, Donahey E, Cappiello Dziedzic JM, Oh L, Greenhalgh E.

Pharmacotherapy. 2015 Feb;35(2):189-97. doi: 10.1002/phar.1522. Epub 2014 Dec 4. Review.

PMID:
25471045
14.

Psychoactive natural products: overview of recent developments.

Ujváry I.

Ann Ist Super Sanita. 2014;50(1):12-27. doi: 10.4415/ANN_14_01_04. Review.

15.

Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions.

Van Hout MC.

Drug Test Anal. 2014 Jul-Aug;6(7-8):778-87. doi: 10.1002/dta.1622. Epub 2014 Mar 11. Review.

PMID:
24619569
16.

An evidence-based systematic review of kratom (Mitragyna speciosa) by the Natural Standard Research Collaboration.

Ulbricht C, Costa D, Dao J, Isaac R, LeBlanc YC, Rhoades J, Windsor RC.

J Diet Suppl. 2013 Jun;10(2):152-70. doi: 10.3109/19390211.2013.793541. Review.

PMID:
23725528
17.

Orally active opioid compounds from a non-poppy source.

Raffa RB, Beckett JR, Brahmbhatt VN, Ebinger TM, Fabian CA, Nixon JR, Orlando ST, Rana CA, Tejani AH, Tomazic RJ.

J Med Chem. 2013 Jun 27;56(12):4840-8. doi: 10.1021/jm400143z. Epub 2013 Apr 8. Review.

PMID:
23517479
18.

Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.

Prozialeck WC, Jivan JK, Andurkar SV.

J Am Osteopath Assoc. 2012 Dec;112(12):792-9. Review.

PMID:
23212430
19.

From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction.

Hassan Z, Muzaimi M, Navaratnam V, Yusoff NH, Suhaimi FW, Vadivelu R, Vicknasingam BK, Amato D, von Hörsten S, Ismail NI, Jayabalan N, Hazim AI, Mansor SM, Müller CP.

Neurosci Biobehav Rev. 2013 Feb;37(2):138-51. doi: 10.1016/j.neubiorev.2012.11.012. Epub 2012 Dec 1. Review.

PMID:
23206666

Supplemental Content

Loading ...
Support Center